Loading...
Loading IPO details...

GPAPL
LISTEDInvestors can bid for minimum 1600 shares (2 lots min for Individual) and in multiples. The table shows min-max investment by Individual and HNI.
| Application | Lots | Shares | Amount |
|---|---|---|---|
Individual(min) | 2 | 3,200 | ₹2.56L |
Individual(max) | 2 | 3,200 | ₹2.56L |
SHNI(min) | 3 | 4,800 | ₹3.84L |
SHNI(max) | 7 | 11,200 | ₹8.96L |
BHNI(min) | 8 | 12,800 | ₹10.24L |
Note: Lot size is 1600 shares at ₹80/share (₹₹1.28L/lot). SME: 2 lots minimum. Limits: Individual ₹0-₹2L, sHNI ₹2L-₹10L, bHNI >₹10L.
Earkart Limited is a HealthTech company specializing in manufacturing and distributing advanced hearing aids and related mobility and educational support products. Founded in 2021, it serves Tier 2 and Tier 3 cities in India and exports to international markets. The company operates through multiple revenue channels including government supply (B2G), retailers/distributors, and a Shop-in-Shop franchise model providing audiology services in clinics.
Despite strong growth potential and a niche healthcare focus, the IPO shows weak market demand and high investment minimums. Valuation is on the higher side for a small-scale company with operational risks. The SME platform listing poses liquidity concerns. Conservative investors may avoid, while speculative investors might consider listing gains but with caution.
Analyst Notes: Automated research generated via Perplexity AI
Latest category-wise demand and applications received
| Category | Subscribed | Applications | Shares applied |
|---|---|---|---|
| IND | 7.53x | 3,327 / 442 | 1,06,46,400 |
| Other | 8.47x | 1,524 / 294 | 1,19,71,200 |